Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | ADK | P55263 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 1/20 | 0.43 |
| ▸ | CCR8 | P51685 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20987228 | 0.89 | NISCH (0.63) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL24575910 | 0.89 | KDM4E (0.64) | NISCHMTORADKALDH1A1ADRA2A | |
| SCHEMBL29079328 | 0.88 | NISCH (0.47) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL31374443 | 0.86 | NISCH (0.46) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL309114 | 0.86 | CCR1 (0.54) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL14304159 | 0.86 | NISCH (0.46) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL3050014 | 0.86 | NISCH (0.46) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL4766313 | 0.86 | NISCH (0.46) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL12354743 | 0.84 | NISCH (0.41) | NISCHMTORADKALDH1A1MEN1 | |
| SCHEMBL7419102 | 0.82 | NISCH (0.42) | NISCHMTORADKALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115466275-B | Latent fingerprint fluorescent visual identification probe and method on substrate | 复旦大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119823102-A | Pyridine imidazole derivative and preparation method and application thereof | 广东科学技术职业学院 | 2025-04-15 | — | — | CN | claimed |
| CN-118359586-A | Spin cross conduction bifunctional complex, preparation method and application thereof | 大连理工大学 | 2024-07-19 | — | — | CN | claimed |
| CN-115466275-A | Fluorescent visual identification probe and method for latent fingerprints on substrate | 复旦大学 | 2022-12-13 | — | — | CN | claimed |
| CN-113336778-A | Fluorescent visual identification probe and method for latent fingerprints on substrate | 复旦大学 | 2021-09-03 | — | — | CN | claimed |
| WO-2018213821-A1 | CATALYSTS FOR THE TRANSFORMATION OF CARBON DIOXIDE AND GLYCEROL TO FORMIC ACID AND LACTIC ACID AND METHODS OF MAKING THE SAME | THE GEORGE WASHINGTON UNIVERSITY (US) | 2018-11-22 | — | — | WO | claimed |
| EP-2920186-B1 | NOVEL GOLD(III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR APPLICATIONS IN CANCER TREATMENT AND THIOL DETECTION | UNIV HONG KONG (CN) | 2018-06-27 | — | — | EP | claimed |
| EP-2920186-A1 | NOVEL GOLD(III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR APPLICATIONS IN CANCER TREATMENT AND THIOL DETECTION | The University of Hong Kong (CN) | 2015-09-23 | — | — | EP | claimed |
| US-8828984-B2 | Gold(III) complexes containing N-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection | THE UNIVERSITY OF HONG KONG (CN) | 2014-09-09 | — | — | US | claimed |
| US-20140142080-A1 | NOVEL GOLD(III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR APPLICATIONS IN CANCER TREATMENT AND THIOL DETECTION | UNIVERSITY OF HONG KONG (CN) | 2014-05-22 | — | — | US | claimed |
| WO-2014075394-A1 | NOVEL GOLD(III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR APPLICATIONS IN CANCER TREATMENT AND THIOL DETECTION | THE UNIVERSITY OF HONG KONG (CN) | 2014-05-22 | — | — | WO | claimed |
| CN-122011354-A | Biimidazole catalyst for liquid crystal polyarylester synthesis and application thereof | 浙江海利得科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250377357-A1 | SELF-ACTUATING SIGNAL PRODUCING DETECTION DEVICES AND METHODS | RED IVORY LLC (US) | 2025-12-11 | — | — | US | disclosed |
| CN-115466275-B | Latent fingerprint fluorescent visual identification probe and method on substrate | 复旦大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-115466275-B | Latent fingerprint fluorescent visual identification probe and method on substrate | 复旦大学 | 2025-05-09 | — | — | CN | disclosed |
| US-6338790-B1 | DETECTION OF BIOANALYTES IN A SMALL VOLUME SAMPLE; CONCENTRATION OF A BIOMOLECULE, SUCH AS GLUCOSE OR LACTATE, USING TECHNIQUES SUCH AS COULOMETRY, AMPEROMETRY, AND POTENTIOMETRY. AN ENZYME CAPABLE OF CATALYZING THE | THERASENSE, INC. | 2002-01-15 | — | — | US | disclosed |
| US-6299757-B1 | ANALYTICAL SENSORS FOR THE DETECTION OF BIOANALYTES; ESPECIALLY MONITORING GLUCOSE LEVELS IN DIABETIC PATIENTS | THERASENSE, INC. | 2001-10-09 | — | — | US | disclosed |
| US-6294281-B1 | Biological fuel cell and method | THERASENSE, INC. | 2001-09-25 | — | — | US | disclosed |
| EP-1119637-A1 | SMALL VOLUME $i(IN VITRO) ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR | Therasense, Inc. (US) | 2001-08-01 | — | — | EP | disclosed |
| WO-2000020626-A1 | SMALL VOLUME IN VITRO ANALYTE SENSOR WITH DIFFUSIBLE OR NON-LEACHABLE REDOX MEDIATOR | THERASENSE, INC. (US) | 2000-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142080-A1 | NOVEL GOLD(III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR APPLICATIONS IN CANCER TREATMENT AND THIOL DETECTION | TXNRD3, TXNRD1, TXN | NISCH 721/4885MTOR 3855/4885ADK 3130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.